Working to Eradicate Gynecologic Cancers

25
TP53 mutations in circulating tumor DNA for response monitoring in patients with high grade serous carcinoma of ovary

Sunday, March 29, 2015: 2:29 PM
International Ballroom (Hilton Chicago)
Y. M. Kim1, S. W. Lee1, H. Y. Lee2, S. E. Lee2, Y. R. Park3, J. H. Kim1, Y. T. Kim1 and J. H. Nam1
1University of Ulsan College of Medicine, ASAN Medical Center, Seoul, South Korea, 2Asan Institute for Life Sciences, Seoul, South Korea, 3Asan Medical Center, Seoul, South Korea